The Fatty Acid Biosynthesis Enzyme FabI Plays a Key Role in the Development of Liver-Stage Malarial Parasites

Min Yu, T. R Santha Kumar, Louis J. Nkrumah, Alida Coppi, Silke Retzlaff, Celeste D. Li, Brendan J. Kelly, Pedro A. Moura, Viswanathan Lakshmanan, Joel S. Freundlich, Juan Carlos Valderramos, Catherine Vilcheze, Mark Siedner, Jennifer H C Tsai, Brie Falkard, Amar bir Singh Sidhu, Lisa A. Purcell, Paul Gratraud, Laurent Kremer, Andrew P. WatersGuy Schiehser, David P. Jacobus, Chris J. Janse, Arba L Ager, William R. Jacobs, James C. Sacchettini, Volker Heussler, Photini Sinnis, David A. Fidock

Research output: Contribution to journalArticle

197 Citations (Scopus)

Abstract

The fatty acid synthesis type II pathway has received considerable interest as a candidate therapeutic target in Plasmodium falciparum asexual blood-stage infections. This apicoplast-resident pathway, distinct from the mammalian type I process, includes FabI. Here, we report synthetic chemistry and transfection studies concluding that Plasmodium FabI is not the target of the antimalarial activity of triclosan, an inhibitor of bacterial FabI. Disruption of fabI in P. falciparum or the rodent parasite P. berghei does not impede blood-stage growth. In contrast, mosquito-derived, FabI-deficient P. berghei sporozoites are markedly less infective for mice and typically fail to complete liver-stage development in vitro. This defect is characterized by an inability to form intrahepatic merosomes that normally initiate blood-stage infections. These data illuminate key differences between liver- and blood-stage parasites in their requirements for host versus de novo synthesized fatty acids, and create new prospects for stage-specific antimalarial interventions.

Original languageEnglish (US)
Pages (from-to)567-578
Number of pages12
JournalCell Host and Microbe
Volume4
Issue number6
DOIs
StatePublished - Dec 11 2008

Fingerprint

Parasites
Fatty Acids
Liver
Antimalarials
Enzymes
Plasmodium falciparum
Apicoplasts
Triclosan
Sporozoites
Plasmodium
Infection
Culicidae
Transfection
Rodentia
Growth
Therapeutics

Keywords

  • CHEMBIO
  • MICROBIO

ASJC Scopus subject areas

  • Immunology and Microbiology(all)
  • Cancer Research
  • Molecular Biology

Cite this

Yu, M., Kumar, T. R. S., Nkrumah, L. J., Coppi, A., Retzlaff, S., Li, C. D., ... Fidock, D. A. (2008). The Fatty Acid Biosynthesis Enzyme FabI Plays a Key Role in the Development of Liver-Stage Malarial Parasites. Cell Host and Microbe, 4(6), 567-578. https://doi.org/10.1016/j.chom.2008.11.001

The Fatty Acid Biosynthesis Enzyme FabI Plays a Key Role in the Development of Liver-Stage Malarial Parasites. / Yu, Min; Kumar, T. R Santha; Nkrumah, Louis J.; Coppi, Alida; Retzlaff, Silke; Li, Celeste D.; Kelly, Brendan J.; Moura, Pedro A.; Lakshmanan, Viswanathan; Freundlich, Joel S.; Valderramos, Juan Carlos; Vilcheze, Catherine; Siedner, Mark; Tsai, Jennifer H C; Falkard, Brie; Sidhu, Amar bir Singh; Purcell, Lisa A.; Gratraud, Paul; Kremer, Laurent; Waters, Andrew P.; Schiehser, Guy; Jacobus, David P.; Janse, Chris J.; Ager, Arba L; Jacobs, William R.; Sacchettini, James C.; Heussler, Volker; Sinnis, Photini; Fidock, David A.

In: Cell Host and Microbe, Vol. 4, No. 6, 11.12.2008, p. 567-578.

Research output: Contribution to journalArticle

Yu, M, Kumar, TRS, Nkrumah, LJ, Coppi, A, Retzlaff, S, Li, CD, Kelly, BJ, Moura, PA, Lakshmanan, V, Freundlich, JS, Valderramos, JC, Vilcheze, C, Siedner, M, Tsai, JHC, Falkard, B, Sidhu, ABS, Purcell, LA, Gratraud, P, Kremer, L, Waters, AP, Schiehser, G, Jacobus, DP, Janse, CJ, Ager, AL, Jacobs, WR, Sacchettini, JC, Heussler, V, Sinnis, P & Fidock, DA 2008, 'The Fatty Acid Biosynthesis Enzyme FabI Plays a Key Role in the Development of Liver-Stage Malarial Parasites', Cell Host and Microbe, vol. 4, no. 6, pp. 567-578. https://doi.org/10.1016/j.chom.2008.11.001
Yu, Min ; Kumar, T. R Santha ; Nkrumah, Louis J. ; Coppi, Alida ; Retzlaff, Silke ; Li, Celeste D. ; Kelly, Brendan J. ; Moura, Pedro A. ; Lakshmanan, Viswanathan ; Freundlich, Joel S. ; Valderramos, Juan Carlos ; Vilcheze, Catherine ; Siedner, Mark ; Tsai, Jennifer H C ; Falkard, Brie ; Sidhu, Amar bir Singh ; Purcell, Lisa A. ; Gratraud, Paul ; Kremer, Laurent ; Waters, Andrew P. ; Schiehser, Guy ; Jacobus, David P. ; Janse, Chris J. ; Ager, Arba L ; Jacobs, William R. ; Sacchettini, James C. ; Heussler, Volker ; Sinnis, Photini ; Fidock, David A. / The Fatty Acid Biosynthesis Enzyme FabI Plays a Key Role in the Development of Liver-Stage Malarial Parasites. In: Cell Host and Microbe. 2008 ; Vol. 4, No. 6. pp. 567-578.
@article{db7936ed6a294c8d95f6389914c0d438,
title = "The Fatty Acid Biosynthesis Enzyme FabI Plays a Key Role in the Development of Liver-Stage Malarial Parasites",
abstract = "The fatty acid synthesis type II pathway has received considerable interest as a candidate therapeutic target in Plasmodium falciparum asexual blood-stage infections. This apicoplast-resident pathway, distinct from the mammalian type I process, includes FabI. Here, we report synthetic chemistry and transfection studies concluding that Plasmodium FabI is not the target of the antimalarial activity of triclosan, an inhibitor of bacterial FabI. Disruption of fabI in P. falciparum or the rodent parasite P. berghei does not impede blood-stage growth. In contrast, mosquito-derived, FabI-deficient P. berghei sporozoites are markedly less infective for mice and typically fail to complete liver-stage development in vitro. This defect is characterized by an inability to form intrahepatic merosomes that normally initiate blood-stage infections. These data illuminate key differences between liver- and blood-stage parasites in their requirements for host versus de novo synthesized fatty acids, and create new prospects for stage-specific antimalarial interventions.",
keywords = "CHEMBIO, MICROBIO",
author = "Min Yu and Kumar, {T. R Santha} and Nkrumah, {Louis J.} and Alida Coppi and Silke Retzlaff and Li, {Celeste D.} and Kelly, {Brendan J.} and Moura, {Pedro A.} and Viswanathan Lakshmanan and Freundlich, {Joel S.} and Valderramos, {Juan Carlos} and Catherine Vilcheze and Mark Siedner and Tsai, {Jennifer H C} and Brie Falkard and Sidhu, {Amar bir Singh} and Purcell, {Lisa A.} and Paul Gratraud and Laurent Kremer and Waters, {Andrew P.} and Guy Schiehser and Jacobus, {David P.} and Janse, {Chris J.} and Ager, {Arba L} and Jacobs, {William R.} and Sacchettini, {James C.} and Volker Heussler and Photini Sinnis and Fidock, {David A.}",
year = "2008",
month = "12",
day = "11",
doi = "10.1016/j.chom.2008.11.001",
language = "English (US)",
volume = "4",
pages = "567--578",
journal = "Cell Host and Microbe",
issn = "1931-3128",
publisher = "Cell Press",
number = "6",

}

TY - JOUR

T1 - The Fatty Acid Biosynthesis Enzyme FabI Plays a Key Role in the Development of Liver-Stage Malarial Parasites

AU - Yu, Min

AU - Kumar, T. R Santha

AU - Nkrumah, Louis J.

AU - Coppi, Alida

AU - Retzlaff, Silke

AU - Li, Celeste D.

AU - Kelly, Brendan J.

AU - Moura, Pedro A.

AU - Lakshmanan, Viswanathan

AU - Freundlich, Joel S.

AU - Valderramos, Juan Carlos

AU - Vilcheze, Catherine

AU - Siedner, Mark

AU - Tsai, Jennifer H C

AU - Falkard, Brie

AU - Sidhu, Amar bir Singh

AU - Purcell, Lisa A.

AU - Gratraud, Paul

AU - Kremer, Laurent

AU - Waters, Andrew P.

AU - Schiehser, Guy

AU - Jacobus, David P.

AU - Janse, Chris J.

AU - Ager, Arba L

AU - Jacobs, William R.

AU - Sacchettini, James C.

AU - Heussler, Volker

AU - Sinnis, Photini

AU - Fidock, David A.

PY - 2008/12/11

Y1 - 2008/12/11

N2 - The fatty acid synthesis type II pathway has received considerable interest as a candidate therapeutic target in Plasmodium falciparum asexual blood-stage infections. This apicoplast-resident pathway, distinct from the mammalian type I process, includes FabI. Here, we report synthetic chemistry and transfection studies concluding that Plasmodium FabI is not the target of the antimalarial activity of triclosan, an inhibitor of bacterial FabI. Disruption of fabI in P. falciparum or the rodent parasite P. berghei does not impede blood-stage growth. In contrast, mosquito-derived, FabI-deficient P. berghei sporozoites are markedly less infective for mice and typically fail to complete liver-stage development in vitro. This defect is characterized by an inability to form intrahepatic merosomes that normally initiate blood-stage infections. These data illuminate key differences between liver- and blood-stage parasites in their requirements for host versus de novo synthesized fatty acids, and create new prospects for stage-specific antimalarial interventions.

AB - The fatty acid synthesis type II pathway has received considerable interest as a candidate therapeutic target in Plasmodium falciparum asexual blood-stage infections. This apicoplast-resident pathway, distinct from the mammalian type I process, includes FabI. Here, we report synthetic chemistry and transfection studies concluding that Plasmodium FabI is not the target of the antimalarial activity of triclosan, an inhibitor of bacterial FabI. Disruption of fabI in P. falciparum or the rodent parasite P. berghei does not impede blood-stage growth. In contrast, mosquito-derived, FabI-deficient P. berghei sporozoites are markedly less infective for mice and typically fail to complete liver-stage development in vitro. This defect is characterized by an inability to form intrahepatic merosomes that normally initiate blood-stage infections. These data illuminate key differences between liver- and blood-stage parasites in their requirements for host versus de novo synthesized fatty acids, and create new prospects for stage-specific antimalarial interventions.

KW - CHEMBIO

KW - MICROBIO

UR - http://www.scopus.com/inward/record.url?scp=57049187017&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57049187017&partnerID=8YFLogxK

U2 - 10.1016/j.chom.2008.11.001

DO - 10.1016/j.chom.2008.11.001

M3 - Article

C2 - 19064257

AN - SCOPUS:57049187017

VL - 4

SP - 567

EP - 578

JO - Cell Host and Microbe

JF - Cell Host and Microbe

SN - 1931-3128

IS - 6

ER -